Literature DB >> 18716027

Increased blood pressure in mice lacking cytochrome P450 2J5.

Krairerk Athirakul1, J Alyce Bradbury, Joan P Graves, Laura M DeGraff, Jixiang Ma, Yun Zhao, John F Couse, Raymond Quigley, David R Harder, Xueying Zhao, John D Imig, Theresa L Pedersen, John W Newman, Bruce D Hammock, Alan J Conley, Kenneth S Korach, Thomas M Coffman, Darryl C Zeldin.   

Abstract

The cytochrome P450 (CYP) enzymes participate in a wide range of biochemical functions, including metabolism of arachidonic acid and steroid hormones. Mouse CYP2J5 is abundant in the kidney where its products, the cis-epoxyeicosatrienoic acids (EETs), modulate sodium transport and vascular tone. To define the physiological role of CYP2J5 in the kidney, knockout mice were generated using a conventional gene targeting approach. Cyp2j5 (-/-) mice develop normally and exhibit no overt renal pathology. While renal EET biosynthesis was apparently unaffected by the absence of CYP2J5, deficiency of this CYP in female mice was associated with increased blood pressure, enhanced proximal tubular transport rates, and exaggerated afferent arteriolar responses to angiotensin II and endothelin I. Interestingly, plasma 17beta-estradiol levels were reduced in female Cyp2j5 (-/-) mice and estrogen replacement restored blood pressure and vascular responsiveness to normal levels. There was no evidence of enhanced estrogen metabolism, or altered expression or activities of steroidogenic enzymes in female Cyp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone were inappropriately low. Together, our findings illustrate a sex-specific role for CYP2J5 in regulation of blood pressure, proximal tubular transport, and afferent arteriolar responsiveness via an estrogen-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18716027      PMCID: PMC2614614          DOI: 10.1096/fj.08-114413

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  69 in total

1.  Afferent arteriolar reactivity to angiotensin II is enhanced during the early phase of angiotensin II hypertension.

Authors:  J D Imig
Journal:  Am J Hypertens       Date:  2000-07       Impact factor: 2.689

2.  Effects of 20-HETE and 19(S)-HETE on rabbit proximal straight tubule volume transport.

Authors:  R Quigley; M Baum; K M Reddy; J C Griener; J R Falck
Journal:  Am J Physiol Renal Physiol       Date:  2000-06

3.  Porcine gonadal and placental isozymes of aromatase cytochrome P450: sub-cellular distribution and support by NADPH-cytochrome P450 reductase.

Authors:  C J Corbin; J M Trant; A J Conley
Journal:  Mol Cell Endocrinol       Date:  2001-02-14       Impact factor: 4.102

Review 4.  Altering genes in animals by gene targeting.

Authors:  B H Koller; O Smithies
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

5.  Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system.

Authors:  J F Reckelhoff; H Zhang; K Srivastava
Journal:  Hypertension       Date:  2000-01       Impact factor: 10.190

6.  Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism.

Authors:  R K Dubey; E K Jackson; P J Keller; B Imthurn; M Rosselli
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

7.  Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.

Authors:  Z Yu; L M Huse; P Adler; L Graham; J Ma; D C Zeldin; D L Kroetz
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

Review 8.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.

Authors:  J H Capdevila; J R Falck; R C Harris
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

Review 9.  Cytochrome P450 metabolites of arachidonic acid in the control of renal function.

Authors:  K G Maier; R J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-01       Impact factor: 2.894

Review 10.  20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure.

Authors:  J C McGiff; J Quilley
Journal:  Curr Opin Nephrol Hypertens       Date:  2001-03       Impact factor: 2.894

View more
  32 in total

Review 1.  Targeting epoxides for organ damage in hypertension.

Authors:  John D Imig
Journal:  J Cardiovasc Pharmacol       Date:  2010-10       Impact factor: 3.105

2.  Contributions of the three CYP1 monooxygenases to pro-inflammatory and inflammation-resolution lipid mediator pathways.

Authors:  Senad Divanovic; Jesmond Dalli; Lucia F Jorge-Nebert; Christopher L Karp; Charles N Serhan; Daniel W Nebert; Leah M Flick; Marina Gálvez-Peralta; Nicholas D Boespflug; Traci E Stankiewicz; Jonathan M Fitzgerald; Maheshika Somarathna
Journal:  J Immunol       Date:  2013-08-16       Impact factor: 5.422

3.  Soluble epoxide hydrolase-dependent regulation of myogenic response and blood pressure.

Authors:  Dong Sun; Azita J Cuevas; Katherine Gotlinger; Sung Hee Hwang; Bruce D Hammock; Michal L Schwartzman; An Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-02-21       Impact factor: 4.733

4.  The arachidonic acid monooxygenase: from biochemical curiosity to physiological/pathophysiological significance.

Authors:  Jorge H Capdevila; John R Falck
Journal:  J Lipid Res       Date:  2018-08-28       Impact factor: 5.922

5.  Characterization of four new mouse cytochrome P450 enzymes of the CYP2J subfamily.

Authors:  Joan P Graves; Matthew L Edin; J Alyce Bradbury; Artiom Gruzdev; Jennifer Cheng; Fred B Lih; Tiwanda A Masinde; Wei Qu; Natasha P Clayton; James P Morrison; Kenneth B Tomer; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2013-01-11       Impact factor: 3.922

Review 6.  Cytochrome P450 and Lipoxygenase Metabolites on Renal Function.

Authors:  John D Imig; Md Abdul Hye Khan
Journal:  Compr Physiol       Date:  2015-12-15       Impact factor: 9.090

7.  Quantitative Polymerase Chain Reaction Analysis of the Mouse Cyp2j Subfamily: Tissue Distribution and Regulation.

Authors:  Joan P Graves; Artiom Gruzdev; J Alyce Bradbury; Laura M DeGraff; Huiling Li; John S House; Samantha L Hoopes; Matthew L Edin; Darryl C Zeldin
Journal:  Drug Metab Dispos       Date:  2015-05-20       Impact factor: 3.922

8.  The superovulated environment, independent of embryo vitrification, results in low birthweight in a mouse model.

Authors:  Rachel Weinerman; Teri Ord; Marisa S Bartolomei; Christos Coutifaris; Monica Mainigi
Journal:  Biol Reprod       Date:  2017-07-01       Impact factor: 4.285

9.  Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice.

Authors:  Komal Sodhi; Kazuyoshi Inoue; Katherine H Gotlinger; Martina Canestraro; Luca Vanella; Dong Hyun Kim; Vijay L Manthati; Sreenivasulu Reddy Koduru; John R Falck; Michal L Schwartzman; Nader G Abraham
Journal:  J Pharmacol Exp Ther       Date:  2009-08-28       Impact factor: 4.030

10.  The epoxygenases CYP2J2 activates the nuclear receptor PPARalpha in vitro and in vivo.

Authors:  Jessica A Wray; Mary C Sugden; Darryl C Zeldin; Gemma K Greenwood; Salma Samsuddin; Laura Miller-Degraff; J Alyce Bradbury; Mark J Holness; Timothy D Warner; David Bishop-Bailey
Journal:  PLoS One       Date:  2009-10-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.